Blackhawk Chiropractic,inc Chiropractor Medicare: Medicare Enrolled Practice Location: 3602 Darlington Rd, Darlington, PA 16115 Phone: 724-827-2400 Fax: 724-827-2500 |
Richard Eric Tsai, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 3602 Darlington Rd, Darlington, PA 16115 Phone: 724-827-2400 Fax: 724-827-2500 |
Courtney M Welsh, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3602 Darlington Rd, Darlington, PA 16115 Phone: 724-827-2400 |
Dr. Nico Rocco, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3602 Darlington Rd, Darlington, PA 16115 Phone: 724-827-2167 Fax: 724-827-2500 |
News Archive
Even as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus continues to cause thousands of cases every day, with many deaths, life continues to move on regardless. Births occur as usual, and in many countries, mothers prefer to breastfeed their babies, at least for the first few months of life.
EarlySense Ltd., the market leader in contact-free monitoring solutions for the hospital and home, announced today it has signed a partnership agreement with Mitsui & Co., Ltd., one of the largest general trading companies in Japan, with revenues of 55.7 Billion USD and net income of 4,099 Million USD for the year ended March 31st, 2014.
Our immune systems are in a constant battle with foreign invaders to keep our bodies healthy. Outside forces like pollution, poor nutrition and new strains of disease keep our immune systems at an overly boosted or inflamed state, which affects energy levels, body and emotional health and overall quality of life. Through inflammatory immune cells, our bodies fight to defend us from this onslaught. Too few of these cells can result in illness, while too many could lead to a high immune response, resulting in heightened inflammation and collateral damage to the body's once-healthy tissues.
Just in time for the SfN Neuroscience 2010 Conference in San Diego, USA, SMI launches the RED500. The RED500 is the world's first high-performance and high-speed remote eye tracker, with 500Hz sampling rate, binocular tracking and a large tracking range.
Hospira today announced that Inflectra (infliximab), the first monoclonal antibody (mAb) biosimilar therapy, has been registered in Australia. This registration paves the way for the Federal Government to reduce the cost of some of the most expensive medicines on the Pharmaceutical Benefits Scheme (PBS).
› Verified 8 days ago